Center-Authored Papers

Filters: Author is Rowland, Kendrith M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Philip PA, Benedetti JK, Corless CL, Wong R, O'Reilly EM, Flynn PJ, Rowland KM, Atkins JN, Mirtsching BC, Rivkin SE et al..  2010.  Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3605-10. Abstract
M
Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE, Flynn PJ, O'Reilly EM et al..  2010.  Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3611-6. Abstract
Markman M, Moon J, Wilczynski S, Lopez AM, Rowland KM, Michelin DP, Lanzotti VJ, Anderson GL, Alberts DS.  2010.  Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.. Gynecologic oncology. 116(3):323-5. Abstract